Sandesh Kanchugal P., Elmir Jagudin, Gustavo M. A. Lima, Vladimir O. Talibov, Afshan Begum, Jie Nan, Mikel Eguiraun, Ana Gonzalez, Céleste Sele, Maria Nyblom, Wolfgang Knecht, Derek T. Logan, Tove Sjögren, Marjolein Thunnissen, Thomas Ursby, Marc Obiols-Rabasa, Magnus Larsson, Uwe Mueller, Tobias Krojer
{"title":"FragMAX Facility for Crystallographic Fragment and Ligand Screening at MAX IV","authors":"Sandesh Kanchugal P., Elmir Jagudin, Gustavo M. A. Lima, Vladimir O. Talibov, Afshan Begum, Jie Nan, Mikel Eguiraun, Ana Gonzalez, Céleste Sele, Maria Nyblom, Wolfgang Knecht, Derek T. Logan, Tove Sjögren, Marjolein Thunnissen, Thomas Ursby, Marc Obiols-Rabasa, Magnus Larsson, Uwe Mueller, Tobias Krojer","doi":"10.1002/appl.202400263","DOIUrl":null,"url":null,"abstract":"<p>The FragMAX facility at MAX IV Laboratory is a state-of-the-art platform for crystallographic fragment screening, designed to support structure-based drug and chemical tool compound discovery. This facility offers a comprehensive workflow, from high-throughput crystal preparation and automated diffraction data collection at the BioMAX beamline to advanced data processing and analysis using custom software tools like FragMAXapp and FragMAXproc. Key components include an extensive relational SQLite database, various fragment libraries, laboratory automation equipment, and a range of bespoke software solutions. FragMAX has conducted numerous successful screening campaigns, serving both academic and industrial users. Users benefit from comprehensive support, and stringent data management. Here, we provide an overview of the different components of the facility and details of their practical implementation.</p>","PeriodicalId":100109,"journal":{"name":"Applied Research","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/appl.202400263","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/appl.202400263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The FragMAX facility at MAX IV Laboratory is a state-of-the-art platform for crystallographic fragment screening, designed to support structure-based drug and chemical tool compound discovery. This facility offers a comprehensive workflow, from high-throughput crystal preparation and automated diffraction data collection at the BioMAX beamline to advanced data processing and analysis using custom software tools like FragMAXapp and FragMAXproc. Key components include an extensive relational SQLite database, various fragment libraries, laboratory automation equipment, and a range of bespoke software solutions. FragMAX has conducted numerous successful screening campaigns, serving both academic and industrial users. Users benefit from comprehensive support, and stringent data management. Here, we provide an overview of the different components of the facility and details of their practical implementation.
MAX IV实验室的FragMAX设备是一个最先进的晶体碎片筛选平台,旨在支持基于结构的药物和化学工具化合物的发现。该设施提供了一个全面的工作流程,从高通量晶体制备和BioMAX光束线的自动衍射数据收集,到使用FragMAXapp和FragMAXproc等定制软件工具进行高级数据处理和分析。关键组件包括广泛的关系SQLite数据库、各种片段库、实验室自动化设备和一系列定制的软件解决方案。FragMAX已经进行了许多成功的筛选活动,服务于学术和工业用户。用户受益于全面的支持和严格的数据管理。在这里,我们概述了该工具的不同组件及其实际实现的细节。